Long-term Monitoring and Care

Living with alkaptonuria (AKU) requires a shift from “reactive” care—treating problems only when they hurt—to “proactive” surveillance. Because the pigment buildup in AKU is silent and gradual, regular monitoring is the way to catch complications before they cause permanent damage. This is especially true if you are taking nitisinone, which requires specific safety checks to protect your vision and metabolic health ^[1][2].

Note for Exogenous Ochronosis (EO): Localized exogenous ochronosis does not itself call for nitisinone, low-protein monitoring, echocardiograms, or stone surveillance. If you have EO, your monitoring will primarily be managed by your dermatologist.

Metabolic Monitoring: The Tyrosine Check

Nitisinone works by blocking the production of HGA, but a side effect is that it causes another substance, tyrosine, to rise in your blood ^[3].

• Fasting Requirements: Tyrosine levels fluctuate throughout the day based on what you eat. To get an accurate reading, some protocols require your blood to be drawn while you are fasting (usually first thing in the morning before breakfast) ^[4].
• Testing Schedule and Targets: In established specialist protocols, tyrosine is often checked at baseline, then at day 4, 3 months, 6 months, and 12 months after starting treatment ^[1][5]. Doctors often aim to keep plasma tyrosine below 500 μmol/L, and may adjust diet if levels exceed 700 μmol/L ^[5]. These targets and schedules are examples from specific centers; follow your own metabolic team’s sampling instructions. Do not change your protein intake or nitisinone dose on your own based on a single result.

Mandatory Eye Surveillance

One of the most important safety rules for nitisinone therapy is the regular slit-lamp examination ^[6].

• The Asymptomatic Risk: High tyrosine levels can cause corneal keratopathy—the formation of tiny crystals in the clear front part of your eye ^[6]. Crucially, these crystals can be completely asymptomatic, meaning you won’t feel them and your vision may seem fine even while they are present ^[6][7].
• Frequency: Specialist centers typically perform an eye exam before you start nitisinone and then periodically (such as every 6 to 12 months) thereafter, though this interval may be more frequent if tyrosine is high ^[8][5].
• What Happens if Crystals are Found? If keratopathy is detected, or if you develop new eye pain, blurred vision, or light sensitivity, your doctor may instruct you to pause or adjust your nitisinone treatment ^[6]. Resolution does not occur on a guaranteed timetable. Do not stop or restart nitisinone without speaking to your prescriber. Treatment is generally only safely adjusted or restarted alongside strict dietary control ^[9].

Cardiovascular and Internal Monitoring

Because the HGA pigment can stiffen heart valves and contribute to stones, internal “check-ups” are often a standard part of long-term AKU care ^[2][10].

• Heart (Echocardiogram): Depending on your age and risk, specialist protocols may recommend periodic echocardiograms (ultrasound of the heart) ^[10]. This monitors for aortic stenosis (narrowing of the heart valve), which affects about 13% to 22% of AKU patients in specialist cohorts, though this risk varies based on age and referral bias ^[11][10].
• Abdomen (Ultrasound): Periodic ultrasounds may be used to check for stones in the kidneys, gallbladder, or prostate (for those with a prostate), which are common but often silent complications of AKU ^[12][13].
• Spine and Joints: Regular clinical assessments, sometimes including specialized scoring like the AKUSSI (AKU Severity Score Index), help track how your joints and spine are responding to treatment over time ^[14].

The goal of this intensive monitoring is to preserve your quality of life. By staying consistent with your labs and specialist checks, you and your medical team can make informed adjustments to your diet or medication dose ^[2].